NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

QTRX

Quanterix Corp

Apr 17 • 04:00PM ET

5.15

Dollar change -0.01
Percentage change -0.19	%

Healthcare • Medical Devices • USA • NASD

Peers: ILMN NTRA TWST GH EXAS TMO ABT DHR BIO QGEN

| Held by: VTI IWM VXF IWN IBB VTWO SCHA VHT DFAT FESM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.00	Insider Own	14.48%	Shs Outstand	38.57M	Perf Week	7.07%
Market Cap	199.76M	Forward P/E	-	EPS next Y	-1.02	Insider Trans	0.00%	Shs Float	33.17M	Perf Month	-28.47%
Income	-38.53M	PEG	-	EPS next Q	-0.44	Inst Own	95.13%	Short Float	7.71%	Perf Quarter	-41.61%
Sales	137.42M	P/S	1.45	EPS this Y	-29.68%	Inst Trans	21.84%	Short Ratio	3.23	Perf Half Y	-58.73%
Book/sh	8.56	P/B	0.60	EPS next Y	21.16%	ROA	-9.17%	Short Interest	2.56M	Perf Year	-67.69%
Cash/sh	7.45	P/C	0.69	EPS next 5Y	12.06%	ROE	-11.33%	52W Range	4.67 - 19.17	Perf YTD	-51.55%
Dividend Est.	-	P/FCF	-	EPS past 5Y	9.19%	ROI	-10.62%	52W High	-73.14%	Beta	1.17
Dividend TTM	-	Quick Ratio	7.88	Sales past 5Y	20.79%	Gross Margin	60.47%	52W Low	10.28%	ATR (14)	0.54
Dividend Ex-Date	-	Current Ratio	8.66	EPS Y/Y TTM	-31.50%	Oper. Margin	-38.29%	RSI (14)	36.29	Volatility	8.57% 8.76%
Employees	471	Debt/Eq	0.11	Sales Y/Y TTM	12.30%	Profit Margin	-28.04%	Recom	1.40	Target Price	13.30
Option/Short	Yes / Yes	LT Debt/Eq	0.10	EPS Q/Q	-29.66%	Payout	-	Rel Volume	1.02	Prev Close	5.16
Sales Surprise	0.75%	EPS Surprise	-17.79%	Sales Q/Q	11.45%	Earnings	Mar 17 AMC	Avg Volume	792.40K	Price	5.15
SMA20	-14.43%	SMA50	-26.13%	SMA200	-53.05%	Trades		Volume	804,495	Change	-0.19%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-01-24	Initiated	Scotiabank	Sector Outperform	$30
Sep-25-23	Upgrade	Canaccord Genuity	Hold → Buy	$25 → $32
Aug-08-23	Upgrade	SVB Securities	Market Perform → Outperform	$30
May-23-23	Upgrade	Goldman	Neutral → Buy	$13 → $27
Aug-15-22	Downgrade	Canaccord Genuity	Buy → Hold	$40 → $12
Aug-09-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$35 → $15
Aug-09-22	Downgrade	Cowen	Outperform → Market Perform	$38 → $18
Mar-02-22	Upgrade	Goldman	Sell → Neutral	$40
Oct-15-21	Resumed	Cowen	Outperform
Jun-04-21	Initiated	Goldman	Sell	$53

Apr-17-25 08:30AM	Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders (Business Wire)
Apr-14-25 08:00AM	Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences (Business Wire) +7.69%
Apr-07-25 08:15AM	Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya (Business Wire) -12.96%
Apr-02-25 09:41AM	Quanterix: Still Many, Many Questions (Seeking Alpha)
Apr-01-25 01:00AM	Quanterix Showcases Innovation Powered by Simoa at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit (Business Wire)
11:03AM	Loading…
Mar-24-25 11:03AM	Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences (Business Wire)
Mar-19-25 04:10PM	SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN (PR Newswire)
Mar-18-25 09:18AM	Q4 2024 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents)
03:01AM	Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
Mar-17-25 04:01PM	Quanterix Releases Financial Results for the Fourth Quarter of 2024 (Business Wire)
04:00PM	Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Todays Earnings Call (Business Wire)
04:00PM	Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results (GlobeNewswire)
Mar-13-25 01:00PM	Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025 (Business Wire)
Mar-11-25 08:00AM	Kent Lake Issues Investor Presentation Detailing Opposition to Quanterixs Proposed Merger with Akoya Biosciences (Business Wire)
Mar-03-25 08:00AM	Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board (Business Wire) -6.59%
06:00AM	Loading…
06:00AM	Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition (Business Wire)
Feb-18-25 03:40PM	Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Companys Proposed Merger with Akoya Biosciences (Business Wire)
Jan-14-25 07:00AM	Quanterix Provides Update on Financial Performance (Business Wire) -5.93%
Jan-10-25 07:00AM	Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers (Business Wire) -19.69%
Jan-06-25 09:30AM	David R. Walt Receives National Medal of Technology and Innovation (Business Wire)
Jan-02-25 04:26PM	Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire) +12.27%
Dec-27-24 04:33AM	Down More Than 60%: Analysts Expect These 2 Beaten-Down Stocks to Rebound in 2025 (TipRanks)
Dec-17-24 06:59AM	Quanterix Expands Capabilities with Strategic Acquisition of EMISSION (Business Wire)
Nov-22-24 05:00PM	Quanterix Announces Receipt of Expected Notice from Nasdaq (Business Wire) +5.70%
07:54AM	Wolf Haldenstein Adler Freeman and Herz LLP announces that it is investigating Quanterix Corporation for potential violations of securities laws (GlobeNewswire)
Nov-21-24 07:00AM	Wolf Haldenstein Adler Freeman and Herz LLP announces that it is investigating Quanterix Corporation for potential violations of securities laws (PR Newswire) +6.35%
Nov-13-24 02:18AM	Quanterix Corp (QTRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Instrument ... (GuruFocus.com) -18.26%
Nov-12-24 04:01PM	Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024 (Business Wire)
Nov-11-24 07:14AM	Quanterix Corp (QTRX) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-05-24 04:00PM	Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024 (Business Wire) +5.99%
04:30PM	Loading…
Oct-28-24 04:30PM	New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer's Disease Diagnostic Information (Business Wire) +5.02%
Oct-09-24 05:55PM	Quanterix Corp (QTRX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amid Regional ... (GuruFocus.com)
Oct-02-24 04:00PM	Quanterix Welcomes Ivana Magovevi-Liebisch, Ph.D., J.D. to Board of Directors (Business Wire)
Sep-30-24 04:00PM	Quanterix Announces Commercialization of p-Tau 217 Test Kit (Business Wire)
Aug-29-24 04:00PM	Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire)
Aug-19-24 04:32PM	Jeffrey Elliott Appointed to Quanterixs Board of Directors (Business Wire) +7.66%
Aug-15-24 07:18PM	Insider Buying: President & CEO Masoud Toloue Acquires Shares of Quanterix Corp (QTRX) (GuruFocus.com) +9.25%
Aug-08-24 05:10PM	Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -14.82%
04:00PM	Quanterix Releases Financial Results for the Second Quarter of 2024 (Business Wire)
Aug-06-24 04:00PM	Quanterix Presenting at Canaccord Genuity 44th Annual Growth Conference (Business Wire) -5.26%
Jul-31-24 04:00PM	Quanterix To Report Second Quarter 2024 Financial Results (Business Wire)
Jul-29-24 10:00AM	Analysts Estimate Quanterix Corporation (QTRX) to Report a Decline in Earnings: What to Look Out for (Zacks) -6.62%
08:00AM	Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimers Disease Detection that is More Effective than Standalone Plasma p-Tau 217 (Business Wire)
Jun-17-24 04:00PM	Quanterix to Participate at the Scotiabank Healthcare 1x1 Day (Business Wire) +5.48%
Jun-05-24 04:00PM	Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference (Business Wire)
May-22-24 04:00PM	Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024 (Business Wire)
May-15-24 09:55AM	Wall Street Analysts Believe Quanterix (QTRX) Could Rally 67.66%: Here's is How to Trade (Zacks) +6.30%
May-09-24 04:45PM	Quanterix Corporation (NASDAQ:QTRX) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:10AM	Quanterix Corp (QTRX) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ... (GuruFocus.com)
May-07-24 09:00PM	QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:10PM	Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Releases Financial Results for the First Quarter of 2024 (Business Wire)
Apr-29-24 04:00PM	Quanterix To Report First Quarter 2024 Financial Results (Business Wire)
11:13AM	Canaccord Genuity Adjusts Price Target on Quanterix to $25 From $32, Maintains Buy Rating (MT Newswires)
Mar-21-24 05:30PM	Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure (Business Wire)
Mar-06-24 09:50AM	Quanterix (QTRX) AD Offering Gets FDA's Breakthrough Device Tag (Zacks)
Mar-04-24 09:00AM	Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimers Disease (Business Wire)
Mar-03-24 08:16AM	Quanterix Corporation (NASDAQ:QTRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 09:26AM	Q4 2023 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents) +12.69%
Feb-29-24 05:10PM	Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023 (Business Wire)
Feb-27-24 10:03AM	Quanterix (QTRX) Expands in Alzheimer's Testing With Alliances (Zacks)
06:34AM	Quanterix Corp (QTRX) Aligns Earnings Release with Annual Report Filing, Reaffirms 2023 Guidance (GuruFocus.com)
Feb-26-24 09:00AM	Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimers Disease (Business Wire)
Feb-23-24 04:30PM	Quanterix to Present at Cowens 44th Annual Health Care Conference (Business Wire)
Feb-16-24 04:00PM	Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call (Business Wire)
Dec-12-23 04:00PM	Quanterix to Present at 42nd Annual J.P. Morgan Healthcare Conference (Business Wire) +8.77%
Dec-04-23 12:00PM	Here's Why Quanterix Corporation (QTRX) is a Great Momentum Stock to Buy (Zacks)
Nov-29-23 09:55AM	Does Quanterix Corporation (QTRX) Have the Potential to Rally 33.74% as Wall Street Analysts Expect? (Zacks)
Nov-13-23 04:00PM	Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (Business Wire) +9.47%
09:55AM	Wall Street Analysts See a 54.88% Upside in Quanterix Corporation (QTRX): Can the Stock Really Move This High? (Zacks)
07:00AM	Sotera Health Appoints Karen Flynn to Board of Directors (GlobeNewswire)
Nov-08-23 12:22PM	Quanterix Corporation (NASDAQ:QTRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-06-23 05:40PM	Quanterix Corp (QTRX) Raises Full-Year Revenue Expectations Following Q3 2023 Results (GuruFocus.com)
05:30PM	7 Stocks to Buy if You Anticipate a Hot November (InvestorPlace)
04:50PM	Quanterix Releases Operating Results for Third Quarter 202 (Business Wire)
Nov-02-23 10:00AM	Analysts Estimate National Vision (EYE) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-30-23 04:00PM	Quanterix to Report Third Quarter 2023 Financial Results on November 7, 2023 (Business Wire) +5.59%
Oct-24-23 04:30PM	Quanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimers Disease (Business Wire) +10.36%
Oct-23-23 08:30PM	Quanterix Announces New Agreement to Advance Blood Based Alzheimer's Disease Detection (Business Wire)
Oct-03-23 12:36PM	Quanterix (QTRX): A Closer Look at Its Modestly Undervalued Status (GuruFocus.com)
Sep-29-23 08:32AM	Zimmer Biomet (ZBH) Gains From ROSA Sales Growth Amid FX Woes (Zacks)
Sep-28-23 05:00PM	Quanterix CEO to Speak at Goldman Sachs Alzheimers Disease Day (Business Wire)
10:37AM	Abbott (ABT) Rides on Nutrition Recovery Amid Low Testing Sales (Zacks)
09:45AM	Quanterix Corporation (QTRX) Moves 7.2% Higher: Will This Strength Last? (Zacks)
Sep-27-23 11:40AM	Quanterix Corp (QTRX): An In-Depth Look at Its Undervalued Status (GuruFocus.com) +7.16%
07:51AM	Here's Why Investors Should Retain STERIS (STE) Stock for Now (Zacks)
07:47AM	Here's Why You Should Buy Align Technology (ALGN) Stock Now (Zacks)
Sep-21-23 09:42AM	Here's Why Investors Should Buy Alcon (ALC) Stock Right Now (Zacks)
Sep-15-23 08:21AM	Here's Why You Should Retain Insulet (PODD) Stock for Now (Zacks)
Sep-13-23 08:16AM	Here's Why You Should Invest in Edward Lifesciences (EW) Now (Zacks)
Sep-06-23 10:04AM	Here's Why You Should Retain Omnicell (OMCL) Stock Now (Zacks)
09:48AM	Why You Should Add Haemonetics (HAE) to Your Portfolio Now (Zacks)
Sep-05-23 08:00AM	Quanterix to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference (Business Wire)
Aug-31-23 08:37AM	Here's Why You Should Retain Integra (IART) Stock for Now (Zacks)
Aug-30-23 09:32AM	Here's Why You Should Retain Zimmer Biomet (ZBH) for Now (Zacks)
Aug-25-23 10:26AM	Integra (IART) CSS Sales Aid, Boston Recall Hurts Growth (Zacks)
09:34AM	BioSig (BSGM) Grows in Arrhythmia Care With Subscription Model (Zacks)
09:14AM	Thermo Fisher's (TMO) EXTENT Solution Makes Commercial Launch (Zacks)
09:04AM	Here's Why You Should Retain Tandem Diabetes (TNDM) Now (Zacks)

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WALT DAVID R	Director	Aug 20 '24	Buy	13.29	47,000	624,630	1,487,342	Sep 17 04:35 PM
Toloue Masoud	President & CEO	Aug 13 '24	Buy	10.90	19,000	207,100	354,119	Aug 15 04:03 PM
OLSON LAURIE J	Director	May 14 '24	Sale	16.98	1,500	25,470	13,738	May 14 04:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

QTRX

Quanterix Corp

Upgrade your FINVIZ experience